Impact of Different Traditional Chinese Medicine Constitutions on the Clinical Outcomes of COVID-19 Patients Infected with SARS-CoV-2 Omicron Variant: A Retrospective Observational Study

被引:1
|
作者
Feng, Hui [1 ]
Qiu, Shanhu [2 ]
Hong, Xiang [3 ]
Ma, Shaolei [4 ]
Hou, Zhenghua [5 ]
Zhu, Kongbo [6 ]
Guo, Ming [1 ]
Wang, Changsong [1 ,9 ]
Huang, Yingzi [7 ,8 ]
机构
[1] Southeast Univ, Zhongda Hosp, Sch Med, Dept Tradit Chinese Med, Nanjing, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Inst Diabet, Sch Med,Dept Gen Practice, Nanjing, Peoples R China
[3] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Nanjing, Peoples R China
[4] Southeast Univ, Zhongda Hosp, Sch Med, Dept Emergency & Crit Care Med, Nanjing, Peoples R China
[5] Southeast Univ, Zhongda Hosp, Sch Med, Dept Psychosomat & Psychiat, Nanjing, Peoples R China
[6] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, Nanjing, Peoples R China
[7] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, Nanjing, Peoples R China
[8] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, 87 Dingjiaqiao Rd, Nanjing 210009, Peoples R China
[9] Southeast Univ, Zhongda Hosp, Sch Med, Dept Tradit Chinese Med, 87 Dingjiaqiao Rd, Nanjing 210009, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2023年 / 16卷
关键词
traditional Chinese medicine constitution; COVID-19; SARS-CoV-2 omicron variant; time to negative nucleic acid test; seven-day conversion rate to negative; NEGATIVE CONVERSION; BODY CONSTITUTION; PREDICTORS; MORTALITY; TIME;
D O I
10.2147/IDR.S424176
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: Traditional Chinese Medicine (TCM) constitution and disease occurrence, development, and prognosis are interrelated. This study aimed to investigate the association between TCM constitution and the time to negative nucleic acid test results in patients with coronavirus disease 2019 (COVID-19) infected with the SARS-CoV-2 Omicron variant.Patients and Methods: We identified COVID-19 patients (>= 18 years) infected with the SARS-CoV-2 Omicron variant and collected clinical data, including clinical symptoms, time to negative nucleic acid test results, and TCM constitution. Linear and logistic regression analyses explored the relationship between TCM constitution and the time to negative nucleic acid test results in patients with the COVID-19 Omicron variant.Results: We included 486 patients with COVID-19, with a mean age of 40.2 years; 321 (66.0%) men and 165 (34.0%) women. Balanced constitution accounted for 43.8%, and unbalanced constitution accounted for 56.2%. Chi-square test showed that different TCM constitutions had significant differences in the influence of clinical symptoms of COVID-19 patients (P < 0.01). After controlling for various factors, multiple linear regression analysis revealed that an unbalanced constitution was significantly positively correlated with time to negative nucleic acid test results (P < 0.05). After controlling for various factors, logistic regression analysis revealed that an unbalanced constitution was closely related to the 7-day nucleic acid test conversion rate (odds ratio (OR): 0.53, 95% confidence interval (CI): 0.36-0.80, P < 0.05). After dividing the unbalanced constitution into deficiency constitution and non-deficiency constitution, the non-deficiency constitution was closely associated with the 7-day nucleic acid test conversion rate (OR = 0.45, 95% CI: 0.28-0.74, P < 0.05). Further analysis revealed that damp-heat constitution in the non-deficiency constitution was associated with the 7-day nucleic acid test conversion rate (OR = 0.33, 95% CI: 0.18-0.60, P < 0.05).Conclusion: In patients with COVID-19, an unbalanced constitution is associated with a longer time to negative nucleic acid test results and lower 7-day nucleic acid test conversion rates.
引用
收藏
页码:6333 / 6344
页数:12
相关论文
共 50 条
  • [1] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
    Zhang, Jianguo
    Zhao, Daguo
    Hu, Jianhui
    Huang, Xing
    Gu, Qingqing
    Tao, Zhimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [3] Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule
    Zhang, Jing
    Liu, Lili
    Zhang, Guoliang
    Li, Mingqiang
    Ma, Bitao
    Yang, Wenming
    BIOSCIENCE TRENDS, 2022, 16 (03) : 238 - 241
  • [4] Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
    Yixuan Wang
    Yan Yao
    Qingfeng Zhang
    Hao Chen
    Yang He
    Ke Hu
    BMC Infectious Diseases, 24
  • [5] Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
    Wang, Yixuan
    Yao, Yan
    Zhang, Qingfeng
    Chen, Hao
    He, Yang
    Hu, Ke
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [6] Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants
    Gunadi
    Hakim, Mohamad Saifudin
    Wibawa, Hendra
    Vujira, Khanza Adzkia
    Puspitarani, Dyah Ayu
    Supriyati, Endah
    Trisnawati, Ika
    Iskandar, Kristy
    El Khair, Riat
    Afiahayati
    Siswanto
    Puspadewi, Yunika
    Irianingsih, Sri Handayani
    Nugrahaningsih, Dwi Aris Agung
    Eryvinka, Laudria Stella
    Utami, Fadila Dyah Trie
    Devana, Edita Mayda
    Aditama, Lanang
    Kinasih, Nathania Christi Putri
    Hediningsih, Yekti
    Ananda, Nur Rahmi
    Arguni, Eggi
    Nuryastuti, Titik
    Wibawa, Tri
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [7] Clinical and laboratory features of COVID-19 patients infected with SARS-CoV-2 variant B.1.1.7 versus those infected with other SARS-CoV-2 strains: A retrospective observational study
    Ergenc, Zeynep
    Ergenc, Hasan
    Ozturk, Ahmet
    Kaya, Gulsum
    Ocak, Ozlem Karaca
    Ince, Ozgur
    JOURNAL OF ACUTE DISEASE, 2022, 11 (06) : 236 - 242
  • [8] Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants
    Mohamad Saifudin Gunadi
    Hendra Hakim
    Khanza Adzkia Wibawa
    Dyah Ayu Vujira
    Endah Puspitarani
    Ika Supriyati
    Kristy Trisnawati
    Riat El Iskandar
    Yunika Khair
    Sri Handayani Afiahayati
    Dwi Aris Agung Siswanto
    Laudria Stella Puspadewi
    Fadila Dyah Trie Irianingsih
    Edita Mayda Nugrahaningsih
    Lanang Eryvinka
    Nathania Christi Putri Utami
    Yekti Devana
    Nur Rahmi Aditama
    Eggi Kinasih
    Titik Hediningsih
    Tri Ananda
    BMC Medical Genomics, 16
  • [9] A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant
    Liu, Changya
    Wu, Xinxin
    Yang, Hongqiang
    Xu, Xiangru
    Chen, Caiyu
    Wu, Linguangjin
    Zhang, Wen
    Shi, Haimei
    Fei, Yuerong
    Sun, Yuting
    Wu, Hongze
    Zhou, Shuang
    Fang, Bangjiang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] Retrospective Cohort Study of COVID-19 in Patients of the Brazilian Public Health System with SARS-CoV-2 Omicron Variant Infection
    Murari, Thiago B.
    Dos Santos Fonseca, Larissa Moraes
    Pereira, Hernane B. de B.
    Nascimento Filho, Aloisio S.
    Saba, Hugo
    Scorza, Fulvio A.
    de Almeida, Antonio-Carlos G.
    Maciel, Ethel L. N.
    Mendes, Jose F. F.
    Rocha Filho, Tarcisio M.
    David, John R.
    Badaro, Roberto
    Souza Machado, Bruna Aparecida
    Moret, Marcelo A.
    VACCINES, 2022, 10 (09)